Neimeth Pharmaceuticals plc has maintained a profitable outlook as evidenced by its Q1 2014 business year unaudited result with a turnover of N469 million compared with N335 million, a 40 percent growth from the corresponding period the previous year.
This performance also permeated every facet of N
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more